https://ir.opthea.com/static-files/bd59ddce-4c9c-46d1-82bf-790ed8b1f827
How did we miss this important and undoubtedly very positive update from last week’s JP Morgan San Francisco Healthcare Conference?!
From page 3 of the presentation:
„P3 clinical trials about 90% enrolled at the beginning of January 2024.
Anticipated patient enrollment: COAST 1Q2024, ShORe 2Q2024.
Topline data expected mid 2025.“
Given OPT‘s rather dire track record when it comes to meeting timelines, this is more than just a comforting bit of news.
The best possible scenario remains intact, that‘s reporting full enrollment BEFORE refinancing to get to top line read out.
https://ir.opthea.com/static-files/bd59ddce-4c9c-46d1-82bf-790ed8...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
-0.035(4.19%) |
Mkt cap ! $984.8M | |||
| Open | High | Low | Value | Volume |
| 82.0¢ | 82.8¢ | 80.0¢ | $2.636M | 3.214M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35676 | 80.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.0¢ | 73544 | 3 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| OPT (ASX) Chart |